Phase I study of in vivo expansion of Melan-A/MART-1 antigen-specific CD8 T lymphocytes following transient immunosuppression in patients with advanced melanoma
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Busulfan; Fludarabine; Melanoma vaccine
- Indications Malignant melanoma
- Focus Adverse reactions
- 03 Dec 2005 New trial record.
- 12 Sep 2005 Biomarkers information updated